No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
510 |
4. Check minimum number of eventsNone |
510 |
5. Include endpointsNone |
510 |
6. Filter based on genotype QC (FinnGen only) |
471 |
Control definitions (FinnGen only)
- Control exclude
- AB1_VIRAL_CNS
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF5
Similar endpoints
↥List of similar endpoints to
Acute poliomyelitis
based on the number of shared cases.
Similar with more cases:
- Viral infections of the central nervous system
- Viral infections of the central nervous system, including avohilmo
- Certain infectious and parasitic diseases
- Certain infectious and parasitic diseases, including avohilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 4599 | 2621 | 1929 |
| Only index persons | 3668 | 2164 | 1504 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.07 | 0.08 | 0.05 |
| Only index persons | 0.07 | 0.08 | 0.06 |
| Median age at first event (years) | |||
| Whole population | 28.96 | 33.25 | 22.55 |
| Only index persons | 25.15 | 31.10 | 16.58 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 471 | 311 | 160 |
| Unadjusted period prevalence (%) | 0.10 | 0.11 | 0.07 |
| Median age at first event (years) | 27.90 | 28.67 | 26.40 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
No data
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 482
- Matched controls
- 4820
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
04599
ICD-8 Finland
Aseptic mentingitis due to enterovirus, Aseptic meningitis, unspecified
+∞
239.1
209
*
04300, ,
ICD-8 Finland
+∞
79.4
74
*
04499
ICD-8 Finland
Late effects of actue poliomyelitis
+∞
56.4
53
*
04597
ICD-8 Finland
Aseptic mentingitis due to enterovirus, Suspecta
+∞
53.1
50
*
B91
ICD-10 Finland
Sequelae of poliomyelitis
72.4
35.6
40
6
1380A
ICD-9 Finland
Late effects of acute poliomyelitis[SEQUELAE POLIOMYELITIDIS]
+∞
24.2
23
*
64090
ICD-8 Finland
Artificial termination of pregnancy performed for medical reasons, Woman's illness or physical defect (medicines. Cause)
7.3
16.7
25
36
04301, ,
ICD-8 Finland
+∞
15.7
15
*
04500
ICD-8 Finland
Aseptic mentingitis due to enterovirus, Coxsackie virus
+∞
15.7
15
*
N70
ICPC
Poliomyelitis
82.7
14.7
16
*
N06AA09
ATC
amitriptyline; systemic
2.5
9.9
66
286
32099
ICD-8 Finland
Meningitis, With no organism specified as cause
22.2
9.4
13
6
N03AX12
ATC
[U] gabapentin; oral
2.1
9.0
100
537
N02AX02
ATC
tramadol; systemic, rectal
1.8
8.3
223
1585
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
3.1
7.8
33
112
SPAT1231
SPAT
Assessment of adjustments needed in living environment
4.5
7.7
19
44
64091
ICD-8 Finland
Medical termination of pregnancy, Weakness (medical-social reason)
3.0
7.1
32
113
J01DA01
ATC
[U] cefalexin
1.7
6.9
303
2417
0459X
ICD-9 Finland
Acute poliomyelitis, unspecified[POLIOMYELITIS ACUTA NUD,NUD]
+∞
6.3
6
*
0451X
ICD-9 Finland
Acute poliomyelitis with other paralysis[POLIOMYEL ACUTA CUM PARALYSI SPINALI/ALIA, NUD]
+∞
6.3
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
111
774
1.56
3.93
2.1
2.0
—
—
—
0
0
254
2106
1.44
3.74
6.5
6.0
1.21
1.21
mmol/l
0.32
227
1941
31
150
2.14
3.66
1.4
1.3
—
—
—
0
0
138
1038
1.46
3.36
2.7
2.2
—
—
—
0
0
43
244
1.84
3.27
5.4
3.2
2.04
1.87
mmol/l
0.11
34
175
147
1124
1.44
3.27
2.4
2.2
3.25
3.04
mg/l
0.49
127
971
78
529
1.57
3.09
5.3
6.8
1.32
1.07
mmol/l
0.19
69
448
46
273
1.76
3.04
1.5
1.9
—
—
—
0
0
84
586
1.52
2.93
1.8
1.9
—
—
—
0
0
29
152
1.97
2.82
2.4
1.9
—
—
—
0
0
270
2334
1.36
2.76
7.2
6.8
1.21
1.22
mmol/l
0.20
213
2016
29
154
1.94
2.72
2.0
1.9
1034.60
313.25
ug/l
0.59
29
145
238
2043
1.33
2.44
5.5
4.6
35.10
35.66
g/l
0.80
221
1917
29
161
1.85
2.41
2.5
2.0
—
—
—
0
0
45
289
1.61
2.26
6.2
3.4
5.34
5.12
kpa
1.02
45
279
243
2109
1.31
2.24
21.3
14.2
1.29
1.25
inr
0.52
210
1745
289
2579
1.30
2.11
5.2
4.8
6.85
6.71
mmol/l
0.49
273
2462
64
453
1.48
2.10
5.7
7.3
122.20
120.71
g/l
0.22
64
444
9
32
2.85
2.01
1.2
1.2
—
—
—
0
0
7
21
3.37
1.97
1.3
1.3
—
—
—
0
0
7
21
3.37
1.97
1.3
1.3
—
—
—
0
0
167
1398
1.30
1.95
2.6
2.6
57.65
63.74
u/l
0.60
152
1293
92
706
1.37
1.95
2.3
2.3
2.34
2.33
g/l
0.08
87
648
51
351
1.51
1.93
1.8
1.6
—
—
—
0
0
73
540
1.41
1.91
5.1
4.9
31.45
32.65
%
0.42
49
339
97
759
1.35
1.82
2.3
2.4
11.41
12.93
umol/l
1.59
92
699
191
1642
1.27
1.78
4.4
3.4
2.36
2.36
mmol/l
0.15
170
1487
74
556
1.39
1.78
1.7
1.9
—
—
—
0
0
6
18
3.36
1.75
1.2
1.3
—
—
—
0
0
8
30
2.69
1.73
1.3
1.4
—
—
—
0
0
8
30
2.69
1.73
1.3
1.4
—
—
—
0
0
10
40
2.53
1.67
3.2
2.3
—
—
—
0
0
207
1810
1.25
1.64
5.0
4.0
42.83
68.56
ng/l
0.37
147
1340
274
2475
1.25
1.62
10.6
9.5
3.98
4.07
e9/l
0.23
235
2178
121
993
1.29
1.62
1.4
1.3
4.67
1.09
u/ml
0.65
31
267
136
1134
1.28
1.60
2.7
2.7
339.13
342.58
umol/l
0.14
118
986
220
1946
1.24
1.55
3.0
2.7
—
—
estimate
—
0
0
157
1338
1.26
1.54
1.9
1.7
21.84
20.62
nmol/l
0.39
128
1125
21
123
1.74
1.53
1.7
1.7
—
—
—
0
0
0
44
0.00
1.52
0.0
1.2
—
—
—
0
0
6
21
2.88
1.51
1.7
1.4
—
—
—
0
0
0
45
0.00
1.50
0.0
1.2
—
—
—
0
0
7
28
2.52
1.45
1.3
1.7
—
—
—
0
0
5
16
3.15
1.44
1.0
2.5
—
—
—
0
0
19
111
1.74
1.41
1.4
1.5
—
—
—
0
0
6
23
2.63
1.37
1.7
1.4
—
—
—
0
0
168
1460
1.23
1.36
3.8
3.2
1150.72
1215.05
ng/l
0.15
142
1241
0
38
0.00
1.35
0.0
1.2
—
—
—
0
0
0
39
0.00
1.34
0.0
1.2
—
—
—
0
0
0
40
0.00
1.33
0.0
1.2
—
—
—
0
0
0
40
0.00
1.33
0.0
1.2
—
—
—
0
0
6
24
2.52
1.30
1.7
1.5
—
—
—
0
0
13
70
1.88
1.25
1.3
1.5
—
—
—
0
0
64
500
1.32
1.24
1.8
2.5
8.32
7.29
umol/l
0.23
59
444
29
197
1.50
1.22
1.7
1.8
1.62
2.50
ug/l
0.22
19
174
352
3316
1.23
1.21
9.4
8.1
77.06
79.09
u/l
0.56
332
3141
9
171
0.52
1.20
1.3
2.2
10.31
10.25
g/l
—
9
154
255
2332
1.20
1.19
3.1
2.8
—
—
—
0
0
66
817
0.78
1.11
3.9
4.0
21.77
21.98
%
0.03
23
340
54
422
1.31
1.06
1.8
1.9
1.79
1.47
%
1.99
49
369
97
818
1.23
1.04
2.0
1.7
1149.16
1213.60
nmol/l
0.26
68
618
5
22
2.29
1.03
1.0
1.0
—
—
—
0
0
74
608
1.26
1.00
1.8
1.5
—
—
—
0
0
420
4321
0.78
0.99
14.8
12.3
25.67
25.57
u/l
0.04
407
4201
18
117
1.56
0.95
1.3
1.3
—
—
—
0
0
14
86
1.65
0.92
1.1
1.2
—
—
—
0
0
113
983
1.20
0.89
1.6
1.7
1.35
1.32
mg/l
0.03
82
767
8
42
1.92
0.89
1.6
3.8
2.61
3.50
nmol/l
—
8
42
21
144
1.48
0.89
1.3
3.5
23.96
2.98
ratio
—
9
82
48
380
1.29
0.88
3.1
2.5
5.55
7.44
ug/l
0.55
38
334
12
191
0.62
0.86
1.6
2.1
7.59
7.46
g/l
0.11
12
175
12
191
0.62
0.86
1.6
2.1
4.07
4.30
g/l
0.46
12
175
12
191
0.62
0.86
1.6
2.1
3.58
3.70
g/l
0.15
12
175
26
188
1.40
0.85
1.6
2.2
1.66
1.49
g/l
0.36
21
171
252
2346
1.16
0.84
7.4
6.4
10.41
11.30
umol/l
1.07
232
2238
10
57
1.77
0.84
1.3
1.2
145.90
336.90
pmol/l
—
10
52
18
121
1.51
0.84
1.3
1.3
—
—
—
0
0
211
1941
1.15
0.83
3.1
2.9
127.58
120.95
ug/l
0.18
193
1797
111
971
1.19
0.82
1.7
1.8
515.34
14462746.84
pmol/l
0.50
82
809
292
2752
1.15
0.81
3.8
3.4
51.19
50.21
u/l
0.07
271
2585
22
156
1.43
0.80
2.2
3.7
40.18
73.32
mg/l
0.59
15
129
22
156
1.43
0.80
2.2
3.7
62.25
88.09
mg/l
0.23
15
130
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
13
82
1.60
0.78
1.3
1.4
—
—
—
0
0
13
82
1.60
0.78
1.3
1.4
—
—
—
0
0
42
333
1.29
0.78
1.6
1.4
—
—
—
0
0
6
34
1.77
0.76
1.0
1.1
—
—
—
0
0
6
34
1.77
0.76
1.0
1.3
—
—
—
0
0
10
59
1.71
0.76
2.8
4.9
329.40
359.98
umol/l
—
10
53
333
3179
1.15
0.74
5.3
4.5
13.97
12.90
mm/h
0.54
312
2957
344
3292
1.16
0.74
4.7
4.5
15.09
14.92
pmol/l
0.56
303
3006
220
2044
1.14
0.73
2.8
2.5
80.85
78.66
nmol/l
0.51
196
1829
13
84
1.56
0.72
1.3
1.5
—
—
—
0
0
169
1842
0.87
0.72
2.1
1.9
1.27
1.37
mmol/l
0.73
126
1535
20
143
1.42
0.71
2.0
2.6
1.16
1.44
mg/l
1.96
20
128
15
101
1.50
0.71
1.3
1.4
—
—
—
0
0
13
85
1.54
0.69
1.3
1.4
—
—
—
0
0
5
27
1.86
0.68
1.4
1.1
—
—
—
0
0
19
136
1.41
0.68
1.2
1.3
—
—
—
0
0
219
2044
1.13
0.66
2.5
2.1
101.10
97.56
pmol/l
0.44
120
1020
21
154
1.38
0.66
1.6
1.4
252.50
286.07
ug/g
0.34
14
95
20
146
1.39
0.64
1.5
2.7
—
—
—
0
0
14
95
1.49
0.64
3.1
2.3
—
—
—
0
0
14
95
1.49
0.64
1.5
1.6
—
—
—
0
0
46
379
1.24
0.64
4.4
3.6
1.24
1.23
mmol/l
0.45
34
334
5
29
1.73
0.64
1.8
2.0
—
—
—
0
0
12
176
0.67
0.63
1.6
2.2
3.39
3.02
g/l
0.35
12
160
0
20
0.00
0.60
0.0
1.4
—
9.85
—
0
20
12
80
1.51
0.60
1.8
1.7
—
—
—
0
0
18
131
1.39
0.60
1.1
1.3
—
—
—
0
0
10
64
1.57
0.59
1.4
1.4
—
—
—
0
0
90
1010
0.87
0.58
4.3
4.8
1.48
2.42
ug/l
1.51
76
908
6
35
1.72
0.58
2.2
1.3
—
—
—
0
0
10
65
1.55
0.56
1.4
1.4
—
—
—
0
0
10
65
1.55
0.56
1.4
1.4
—
—
—
0
0
30
240
1.27
0.55
1.4
1.4
—
—
—
0
0
29
359
0.80
0.54
1.9
2.7
69.00
63.43
ml/min/173m2
0.32
14
152
138
1268
1.12
0.53
3.1
3.7
0.00
0.01
estimate
1.02
40
400
9
62
1.46
0.53
1.1
1.1
—
—
—
0
0
53
454
1.19
0.53
2.8
2.0
373.85
392.45
nmol/l
0.29
47
423
433
4403
0.84
0.52
33.2
25.2
4.38
4.46
e12/l
2.38
427
4304
9
135
0.66
0.52
1.2
1.1
0.82
0.89
g/l
—
9
135
25
197
1.28
0.52
1.0
1.0
—
—
—
0
0
52
446
1.19
0.51
3.6
3.4
—
—
—
0
0
387
3965
0.88
0.51
6.9
6.8
39.88
39.66
mmol/mol
0.17
352
3711
407
4156
0.87
0.50
6.2
6.1
2.70
2.70
mmol/l
0.04
368
3828
15
110
1.38
0.49
3.1
3.2
2.00
1.80
index
—
8
60
35
290
1.22
0.49
4.3
6.4
25.19
24.55
mmol/l
0.48
35
279
7
46
1.53
0.48
1.3
1.9
—
—
—
0
0
58
507
1.16
0.47
9.8
7.2
—
—
—
0
0
7
49
1.43
0.46
1.3
1.8
—
—
—
0
0
33
393
0.83
0.45
2.5
2.6
0.25
0.62
e6/l
0.79
33
372
107
980
1.12
0.44
4.4
2.8
2.47
2.46
mmol/l
0.63
95
885
9
129
0.69
0.44
1.2
1.1
1.56
1.52
g/l
—
9
129
395
4031
0.89
0.42
5.9
5.4
6.01
6.01
mmol/l
0.03
352
3684
398
4059
0.89
0.42
5.4
5.2
1.51
1.50
mmol/l
0.11
358
3738
5
33
1.52
0.41
1.4
1.5
99.20
77.12
ng/l
—
5
33
0
15
0.00
0.41
0.0
1.4
—
1.23
—
0
6
0
15
0.00
0.41
0.0
1.4
—
1.11
—
0
6
0
15
0.00
0.41
0.0
1.6
—
—
—
0
0
0
15
0.00
0.41
0.0
1.4
—
1.32
—
0
6
0
16
0.00
0.41
0.0
3.5
—
205.13
—
0
16
15
114
1.33
0.41
1.3
1.7
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
16
123
1.31
0.41
3.6
2.7
0.29
0.36
iu/ml
—
7
74
55
485
1.15
0.41
5.1
4.3
27.35
22.08
ug/l
0.09
44
406
5
34
1.48
0.40
1.2
1.8
—
—
—
0
0
5
34
1.48
0.40
1.2
1.8
—
—
—
0
0
5
34
1.48
0.40
1.2
1.8
—
—
—
0
0
5
34
1.48
0.40
2.2
3.0
2547.80
832.09
mg
—
5
34
8
60
1.34
0.40
1.0
1.1
—
—
—
0
0
8
60
1.34
0.40
1.6
1.5
—
—
—
0
0
0
18
0.00
0.40
0.0
1.6
—
48.41
—
0
13
46
401
1.16
0.39
2.7
2.5
35.65
34.95
u/l
0.03
40
327
14
106
1.33
0.39
1.1
1.1
—
0.93
—
0
9
165
1555
1.09
0.39
3.5
3.3
6.94
7.21
mmol/l
0.34
133
1307
9
69
1.31
0.37
1.2
3.0
—
1230.83
—
0
6
152
1431
1.09
0.37
2.6
2.2
246.28
184.69
u/l
0.43
146
1362
11
146
0.75
0.36
1.6
2.3
0.00
0.03
g/l
0.50
11
132
139
1306
1.09
0.35
4.3
4.3
0.00
0.01
estimate
0.74
51
452
75
821
0.90
0.35
1.4
1.3
43.64
34.45
iu/ml
0.16
25
261
381
3883
0.91
0.34
4.6
4.4
1.38
1.29
mmol/l
0.59
342
3540
6
45
1.34
0.34
1.2
1.2
—
81.83
—
0
6
6
46
1.31
0.33
1.2
1.4
—
—
—
0
0
19
230
0.82
0.32
2.6
4.0
1.64
1.54
%
0.24
19
217
14
110
1.28
0.32
1.1
1.3
—
—
—
0
0
43
381
1.14
0.31
4.4
3.2
106.89
81.55
ng/l
0.78
36
335
40
353
1.15
0.31
2.1
2.1
3.62
3.45
ratio
0.40
33
287
15
120
1.26
0.30
1.5
1.6
—
—
—
0
0
13
102
1.28
0.30
1.3
1.3
—
—
—
0
0
8
63
1.27
0.28
1.1
1.4
—
—
—
0
0
402
4077
0.92
0.27
5.6
5.4
4.69
4.67
mmol/l
0.17
366
3774
13
104
1.26
0.26
1.9
1.7
5.02
3.61
iu/l
—
7
45
70
755
0.91
0.26
1.3
1.3
18.97
12.78
u/ml
0.26
25
281
27
235
1.16
0.26
2.2
1.8
—
—
—
0
0
109
1029
1.08
0.25
4.2
4.4
1.02
1.02
kg/l
0.51
76
694
56
609
0.91
0.25
2.7
2.9
0.59
0.80
ug/l
1.51
27
348
151
1449
1.06
0.22
2.9
3.3
36.83
31.95
u/l
0.47
144
1366
5
40
1.25
0.22
1.0
1.3
—
—
—
0
0
29
258
1.13
0.21
2.3
1.9
—
—
—
0
0
5
42
1.19
0.21
1.2
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.8
—
1.24
—
0
10
0
10
0.00
0.21
0.0
1.0
—
99.00
—
0
10
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
0.94
—
0
8
141
1467
0.95
0.20
4.0
3.3
299.30
36.50
e6/l
0.47
111
1114
0
14
0.00
0.20
0.0
1.1
—
371.67
—
0
9
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
120
1253
0.94
0.20
4.0
3.1
0.44
0.52
e6/l
0.25
92
908
6
51
1.18
0.19
1.2
1.3
—
—
—
0
0
106
1011
1.06
0.19
2.9
2.7
3.84
6.60
e6/l
2.09
94
922
411
4066
1.07
0.19
22.2
16.5
23.36
23.60
mg/l
0.05
356
3361
159
1535
1.05
0.19
4.5
4.1
5.78
6.74
mg/mmol
0.20
92
933
154
1595
0.95
0.19
4.3
3.2
—
—
—
0
0
14
119
1.18
0.18
3.2
2.1
—
—
—
0
0
7
60
1.17
0.18
2.0
1.5
—
—
—
0
0
7
61
1.15
0.17
1.6
1.4
—
—
—
0
0
7
61
1.15
0.17
1.6
1.4
—
—
—
0
0
7
61
1.15
0.17
2.1
1.4
—
—
—
0
0
7
62
1.13
0.17
1.6
1.4
—
—
—
0
0
11
131
0.84
0.17
1.6
2.4
0.00
0.00
g/l
-0.00
11
124
17
148
1.15
0.17
1.9
1.5
—
—
—
0
0
28
254
1.11
0.16
1.2
1.4
—
28.62
—
0
17
181
1763
1.04
0.15
3.8
4.2
0.00
0.05
estimate
2.42
43
409
24
265
0.90
0.15
1.8
1.9
3.65
3.50
mmol/l
0.36
19
202
11
93
1.19
0.14
10.2
3.8
40.40
30.68
mg/l
—
5
61
12
137
0.87
0.12
1.0
1.4
0.22
0.23
g/l
0.16
12
131
29
269
1.08
0.11
1.2
1.3
118.67
234.00
u/ml
0.90
29
248
67
643
1.05
0.11
6.7
6.0
103.48
103.96
mmol/l
0.31
67
643
13
115
1.13
0.10
1.7
1.5
—
—
—
0
0
5
44
1.14
0.10
1.2
1.1
—
—
—
0
0
10
114
0.87
0.09
1.6
1.4
—
—
—
0
0
15
136
1.11
0.08
1.2
1.2
—
—
—
0
0
15
138
1.09
0.06
1.2
1.2
—
—
—
0
0
383
3849
0.98
0.05
6.2
5.7
1.91
1.94
mu/l
0.17
349
3534
13
141
0.92
0.05
1.0
1.5
1.25
1.16
g/l
0.33
13
134
89
872
1.03
0.05
4.2
4.2
720.18
259.76
ng/l
0.41
69
703
63
616
1.03
0.04
1.5
1.4
—
—
—
0
0
234
2357
0.99
0.04
4.0
4.2
0.00
0.02
estimate
0.93
49
467
27
261
1.04
0.02
5.6
2.9
29.96
70.34
u/ml
1.16
27
254
76
771
0.98
0.02
3.6
2.9
1.13
1.07
e6/l
0.07
42
397
14
148
0.94
0.02
1.1
1.3
32.53
25.88
iu/l
—
9
122
10
93
1.08
0.02
1.4
1.1
6.80
2.24
e6/l
—
5
72
230
2309
0.99
0.01
4.0
4.2
0.00
0.00
estimate
0.50
52
486
11
104
1.06
0.01
1.1
1.2
—
—
—
0
0
28
286
0.98
0.00
2.3
2.6
—
16.07
—
0
23
17
168
1.01
0.00
1.4
1.4
0.29
0.31
mg/l
—
8
71
71
712
1.00
0.00
3.6
3.0
1.44
2.63
e6/l
1.47
37
337
233
2331
1.00
0.00
3.9
4.2
0.00
7.00
estimate
0.80
54
500
395
3954
0.99
0.00
20.8
16.5
79.00
77.57
ml/min/173m2
0.67
370
3675
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
20
200
1.00
-0.00
1.3
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
6.40
—
0
5
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
6
63
0.95
-0.00
2.2
1.3
1.02
30.44
nmol/l
—
6
57
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
65.20
—
0
5
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
62
0.97
-0.00
1.3
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
9.10
—
0
5
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.6
—
40.00
—
0
5
0
6
0.00
-0.00
0.0
2.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint AB1_POLIOMYELITIS and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have AB1_POLIOMYELITIS.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: AB1_POLIOMYELITIS – Acute poliomyelitis
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data